GB Patent

GB2559774B — Oral cannabinoid formulations

Assigned to GW Research Ltd · Expires 2021-09-29 · 5y expired

What this patent protects

Patent listed against Epidiolex.

Drugs covered by this patent

Epidiolex (CANNABIDIOL) · Jazz Pharms Res

Patent Metadata

Patent number: GB2559774B
Jurisdiction: GB
Classification: —
Expires: 2021-09-29
Drug substance claim: No
Drug product claim: No
Assignee: GW Research Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.